Drug · DIN 02417618
MAR-PREGABALIN
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since February 25, 2014.
- Drug Identification Number (DIN)
- 02417618
- Company (DIN owner)
- Marcan Pharmaceuticals Inc.Ottawa, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Pregabalin N02BF02
- Class
- Human
- Record last updated
- June 23, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| PREGABALIN | 300 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 25, 2014: NOC 15317Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies
Other DINs named MAR-PREGABALIN
- DIN 02417529 · Marketed
- DIN 02417537 · Marketed
- DIN 02417545 · Marketed
- DIN 02417561 · Marketed
- DIN 02417553 · Approved
- DIN 02417588 · Approved
- DIN 02417596 · Approved